Hacker News Reader

The jury heard testimony related to patent infringement. It's true that Masimo chose to seek an award for unjust enrichment from trade secret theft instead of damages related to the patents themselves, but that was a strategic choice on their part. They could have requested damages in that same case.

View on HN

But it does speak to their confidence, or lack thereof, in their ability to defend the patent in question.

Couldn’t same confidence could be said for Apple’s actions? Why continue to GTM with relatively minor feature (it’s not 2020 anymore where everyone was worrying about blood oxygen due to covid) that could be easily disabled by software? My sense is that Apple is really confident that they are not infringing on that patent.

Reply on news.ycombinator.com